XTX Topco’s Epizyme, Inc EPZM Stock Holding History

XTX Topco’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-69,097	Closed	-$79K	–	1191
2022 Q1	$79K	Buy	69,097 +58,341	+542%	+$95.1K	0.03%	544
2021 Q4	$27K	Buy	+10,756	New	+$42.3K	0.02%	611

Other funds holding EPZM

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco's EPZM Position: Q2 2022 in Review

XTX Topco sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 69,097 shares — an estimated $79K sold.

XTX Topco first reported a position in EPZM in Q4 2021 and held it in 2 quarters. The position peaked at $79K in Q1 2022. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

XTX Topco reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
XTX Topco sold 69,097 Epizyme, Inc shares in Q2 2022, an estimated $79K.
XTX Topco first reported a position in Epizyme, Inc in Q4 2021 and held it in 2 quarters.
XTX Topco's Epizyme, Inc position peaked at $79K in Q1 2022.
93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on XTX Topco's 13F filing for Q2 2022, filed 15 Aug 2022.